Author: <span>Mesothelioma News</span>

EnGeneIC Unveils Clinical Development Strategy for EDV? Nanocell Technology

U.S. Phase 2a Clinical Trial in Recurrent Glioblastoma to Initiate in Early 2015 Australian Phase 0/1 Clinical Trial in Mesothelioma to Initiate in Third Quarter of 2014 Additional Studies Planned for Non-Small Cell Lung Cancer /PRNewswire/ — EnGeneIC…